IRONDisc Medicine, IncRunning, no new patients
A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)
Polycythemia Vera (PV)
0Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
No warning signs right now. That's why the score is 0.
Score over time
- Stage
- Phase 2
- Patients
- 60 (planned)
- Started
- Aug 12, 2025
- Main results expected
- Jul 2027
- Fully finished
- Jul 2029
- Results posted
- not yet
What counts as success
The trial's main goal(s), called the “primary outcome.”
Number of participants with treatment-related adverse events as assessed by CTCAE
Measured over: Up to 365 days
Incidence of clinically abnormal vital signs
Measured over: Up to 365 days
Incidence of clinically abnormal physical exam
Measured over: Up to 365 days
Incidence of clinically abnormal electrocardiograms
Measured over: Up to 365 days
Incidence of abnormal laboratory test results
Measured over: Up to 365 days
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- none
Raw record changes
- none yet
Trial ID NCT06985147 · record last updated 2026-11-02 · checked 2026-11-09 15:42 UTC